Category

Daily Briefs

Daily Brief Energy/Materials: JSR Corp, Azure Minerals, Lithium Power International, iShares Russell 2000 ETF and more

By | Daily Briefs, Energy & Materials Sector

In today’s briefing:

  • JSR (4185) – Deal Approval Unexpectedly Delayed, As Expected
  • Gina Joins SQM In Bid For Azure (AZS AU)
  • Azure Minerals (AZS AU): SQM/Hancock Team up for a New Offer
  • Lithium Power (LPI AU): Scheme Vote on 23 January
  • Codelco’s Offer For Lithium Power (LPI AU): 23th Jan Shareholder Vote
  • Russell 2000 Testing 1.5+ Year Resistance; Downgrading Communications; Steel Buys $NUE $STLD $ZEUS


JSR (4185) – Deal Approval Unexpectedly Delayed, As Expected

By Travis Lundy

  • Today after the close, JSR Corp (4185 JP) announced that the expected “end-December” commencement of JIC’s Tender Offer to take the company private would be delayed. 
  • This was somewhat expected to widely expected based on initial FUD which then gave way to “specialised reporting” a couple of weeks ago which indicated as much.
  • Here I look at potential implications, spreads, and risks. And it still looks like one has to let it run (and buy a dip).

Gina Joins SQM In Bid For Azure (AZS AU)

By David Blennerhassett

  • This makes life a lot simpler. Gina Rinehart’s Hancock Prospecting will now team up with Chile’s SQM to take control of lithium play Azure Minerals (AZS AU).
  • In a binding Offer, by way of a Scheme, the joint bidders (collectively holding ~37.79%) are offering A$3.70/share, a 5.1% bump in terms to SQM’s prior Scheme Offer. 
  • An off-market takeover at A$3.65/share unfolds IF this Scheme were to fail. If both fail/lapse,  SQM will, “in certain circumstances”, be required to proceed with its off-market transaction of A$3.50/share.

Azure Minerals (AZS AU): SQM/Hancock Team up for a New Offer

By Arun George

  • Azure Minerals (AZS AU) has entered a new transaction implementation deed with Sociedad Quimica y Minera de Chile (SQM US) and Hancock at A$3.70, a 51.6% premium to the undisturbed price.
  • The emergence of Hancock and Mineral Resources (MIN AU) as substantial shareholders necessitated the new offer. The off-market takeover offer is A$3.65 per share if the scheme fails. 
  • The scheme’s completion hinges on MinRes’ acceptance. MinRes could potentially block the scheme but has a history of selling into Hancock offers.

Lithium Power (LPI AU): Scheme Vote on 23 January

By Arun George

  • The Lithium Power International (LPI AU) IE considers Codelco’s A$0.57 offer fair and reasonable as it is above the midpoint of its A$0.30-0.68 per share valuation range. 
  • The scheme is conditional on FIRB approval, which should be forthcoming as LPI’s assets are outside Australia in Chile.
  • Irrevocables represent 32.05% of outstanding shares. At the last close and for the 16 February payment, the gross/annualised spread was 3.6%/26.3%.

Codelco’s Offer For Lithium Power (LPI AU): 23th Jan Shareholder Vote

By David Blennerhassett

  • Back on the 18th October, Lithium Power International (LPI AU) announced it had entered into a Scheme Implementation Deed with Chilean state miner Codelco, the world’s largest copper producer.
  • Codelco offered LPI shareholders A$0.57/share, a heft 119% premium to last close. LPI’s major shareholder, Minera Salar Blanco SpA with 27.88%, is supportive of the Scheme.. 
  • LPI’s Scheme Meeting has now been tabled for the 23 Jan, with implementation expected on the 16 February. The IE is supportive and LPIs board unanimously recommends the transaction.

Russell 2000 Testing 1.5+ Year Resistance; Downgrading Communications; Steel Buys $NUE $STLD $ZEUS

By Joe Jasper

  • The market remains in “lockout rally” mode, where prices continue to move higher with little-to-no pullbacks, while ignoring overbought readings.
  • We have discussed this on a weekly basis since 11/21/23. Still no reason to fight this bullish trend, and we continue to expect more upside into year-end and early 2024.
  • We highlight buys in Steel: NUE, STLD, RS, WOR, TMST, ZEUS, LatAm Banks: ITUB, BSBR, BBD, BAP, BCH, Industrials: ITT, FSS, SPXC, ATS, KAI, CR, BRC, SXI, and HSC

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Industrials: Pan Ocean, Asagami Corp, Bharat Electronics, S.F. Holding, Steelcase Inc Cl A and more

By | Daily Briefs, Industrials

In today’s briefing:

  • Pan Ocean Considering on a Rights Offering Capital Raise of Nearly 3 Trillion Won for the HMM Deal
  • Asagami Corporation – Example of Widespread Undervaluation of Land on Japanese Balance Sheets
  • Quiddity Leaderboard NIFTY Mar 24: Bharat Electronics Trade Successful; Change Hedge and Let It Run
  • Monthly Chinese Express Tracker | Prices Keep Sliding, Volume Share Keeps Shifting (December 2023)
  • Steelcase, Inc. – Earnings After Close Today; Watching Margins, Order Trends


Pan Ocean Considering on a Rights Offering Capital Raise of Nearly 3 Trillion Won for the HMM Deal

By Douglas Kim

  • A consortium led by the Harim Group and JKL Partners has been chosen as the preferred bidder to acquire a 57.9% stake in HMM.
  • Korea Development Bank (KDB) and the Korea Ocean Business Corporation (KOBC) are the main creditors of HMM, which is the largest shipping company in Korea.
  • Pan Ocean is expected to complete a rights offering of nearly 3 trillion won which is 136% of its current market cap. This is excessive and negative for Pan Ocean.

Asagami Corporation – Example of Widespread Undervaluation of Land on Japanese Balance Sheets

By Altay Capital

  • Asagami Corporation (TYO 9311) owns 3 warehouses on Tokyo Harbor with land carried on its books at ¥7.9 billion.
  • These properties alone are likely worth closer to ¥29.5 billion.
  • These assets account for less than half of the company’s land assets, but are worth multiples of the current market cap of just ¥7.16B.

Quiddity Leaderboard NIFTY Mar 24: Bharat Electronics Trade Successful; Change Hedge and Let It Run

By Janaghan Jeyakumar, CFA

  • NIFTY 50 represents the 50 largest stocks listed in the National Stock Exchange (NSE) of India and the NIFTY Next 50 index tracks the next 50 largest names.
  • In this insight, we take a look at the names leading the race to become ADDs/DELs for the NIFTY 50 and NIFTY Next 50 indices in the March 2024 rebalance.
  • There could be multiple changes for NIFTY 50 and separately, there could be five changes for NIFTY Next 50. The NIFTY 50 changes could have high impact.

Monthly Chinese Express Tracker | Prices Keep Sliding, Volume Share Keeps Shifting (December 2023)

By Daniel Hellberg

  • In November, domestic parcel volume growth accelerated vs recent months
  • International remains very strong; STO keeps taking share from Yunda
  • Avoid domestic ‘ground’ segment, seek international growth in SF, CaiNiao

Steelcase, Inc. – Earnings After Close Today; Watching Margins, Order Trends

By Water Tower Research

  • Steelcase reports 3QFY24 results after market close today. We are expecting adjusted EPS of $0.25 on revenue of $804 million.
  • Consensus is EPS of $0.23 on revenue of $796 million.
  • Our estimate is at the high end of the revenue guidance and the midpoint of adjusted EPS guidance. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Health Care: TSE Tokyo Price Index TOPIX, Hutchmed China Ltd, Neuren Pharmaceuticals and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Is the Rise in TOPIX Anticipating the Actual Rise in ROE+DOE?
  • Hutchmed China Ltd (13.HK/​HCM.US) – A Valuable Option in the Portfolio
  • Neuren Pharmaceuticals (NEU AU): Positive Trial Result- A Step Ahead for Potential Second Drug


Is the Rise in TOPIX Anticipating the Actual Rise in ROE+DOE?

By Aki Matsumoto

  • While OP Margin did not improve much, companies did execute a certain degree of shareholder return in the previous fiscal year, but it did not significantly increase ROE.
  • Since companies with lower profits are also increasing shareholder returns, the dividend payout is likely to rise a bit more. It will be interesting to see how much ROE improves.
  • There is a correlation between ROE+DOE and TOPIX. Since TOPIX has risen significantly this year, it will be interesting to see if ROE+DOE actually increases in the future.

Hutchmed China Ltd (13.HK/​HCM.US) – A Valuable Option in the Portfolio

By Xinyao (Criss) Wang

  • The market seems “not excited” with fruquintinib’s FDA approval.We analyzed the potential reasons behind.Beyond boosting market sentiment when license-out deal is announced initially,its practical impact on valuation could be limited.
  • HUTCHMED’s financial performance is good. The deal with Takeda helps to relieve cash-flow pressure. We think HUTCHMED is a relatively safe bet for investors as eventual breakeven is drawing near.
  • If based on conservative calculation, market value of about US$1,455-2,055 million is a good place to long.When market value is higher than US$3,500 million, it’s time to consider taking profits.

Neuren Pharmaceuticals (NEU AU): Positive Trial Result- A Step Ahead for Potential Second Drug

By Tina Banerjee

  • Neuren Pharmaceuticals (NEU AU) has announced positive top-line result from its phase 2 clinical trial of its second drug candidate NNZ-2591 in children with Phelan-McDermid syndrome (PMS), a genetic disorder.
  • PMS has an overwhelming unmet medical need. This is an attractive commercial opportunity with an estimated addressable patient population of 24,000 in the U.S. alone.
  • NNZ-2591 has the potential to become the first FDA-approved drug for PMS. Neuren is also conducting phase 2 clinical trials of NNZ-2591 in children with three other neurodevelopmental disorders.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Financials: Ngern Tid Lor , Mizuho Financial Group, India Shelter Finance, Union Bank Of India, Stylam Industries, Yuexiu Property and more

By | Daily Briefs, Financials

In today’s briefing:

  • SET50 Index Rebalance: KCE Replaces TIDLOR
  • Japanese Banks – No Change to Our Bullish View on the Back of the BoJ’s Pause on Interest Rates
  • India Shelter Finance IPO Trading – Subscription Pulled by Strong Insti Demand
  • AMFI Stock Reclassification Preview (Dec 2023): MidCap to LargeCap Migrations Outperforming
  • Stylam Industries (SYIL IN): Sluggish Exports, FY25 To See Improvements With Expansion
  • Morning Views Asia: Yuexiu Property


SET50 Index Rebalance: KCE Replaces TIDLOR

By Brian Freitas


Japanese Banks – No Change to Our Bullish View on the Back of the BoJ’s Pause on Interest Rates

By Victor Galliano

  • We see Ueda’s pause on lifting its negative rates policy as temporary, and we expect that this policy change could occur as early as January
  • Despite this monetary pause in tightening and the fall in 10Y JGB yields, we are encouraged by the rise in long term loan yields in the BoJ data to October-end
  • We reiterate our positive views on Resona, Mizuho, MUFG and Concordia

India Shelter Finance IPO Trading – Subscription Pulled by Strong Insti Demand

By Clarence Chu

  • India Shelter Finance (0570670D IN) raised around US$144m from its India IPO.
  • India Shelter Finance (ISF) is a retail-focused HFC targeting the self-employed customer with a focus on first time home loan takers in the low and middle income group.
  • We have covered various aspects of the deal in our previous note. In this note, we will talk about the demand and trading dynamics.

AMFI Stock Reclassification Preview (Dec 2023): MidCap to LargeCap Migrations Outperforming

By Brian Freitas

  • We see 8 stocks moving from MidCap to LargeCap, 8 stocks moving from LargeCap to MidCap, 11 stocks from SmallCap to MidCap, and 14 stocks from MidCap to SmallCap.
  • Some stocks were added to global indices last month while some could be added in February. There are potential index implications for the NIFTY Index and Nifty Next 50 Index too.
  • The upward migrations have continued to outperform the downward migrations. The largest recent outperformance has come from stocks expected to move from the Mid Cap to the Large Cap segment.

Stylam Industries (SYIL IN): Sluggish Exports, FY25 To See Improvements With Expansion

By Sameer Taneja

  • While the profitability of Stylam Industries (SYIL IN) is growing healthily (>30% YoY) in H1 FY24 due to margin expansion, revenues are trending at -4.5% YoY.
  • The company became net cash in H1 FY24 (73 crore INR)  and zero gross debt. A strong balance sheet would aid in the company’s expansion plans. 
  • Trading at 23x/18x FY24e/25e, we see strong growth ahead for the company as it cements its position as one of India’s top laminate export players. 

Morning Views Asia: Yuexiu Property

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Consumer: Oriental Land, Kurabo Industries, Hankook & Company, Credo Brands Marketing, China East Education , Soybean Active Contract, Ricegrowers Ltd, Games Workshop Group PLC, Tsuruha Holdings and more

By | Consumer, Daily Briefs

In today’s briefing:

  • Oriental Land: Approaching the Tipping Point
  • Kurabo (3106) – Bigly Buyback And Share Cancellation for A Valueful Value Trap With Hidden Value
  • StubWorld: Hankook’s Bothersome Brothers
  • Credo Brands Marketing IPO- Forensic Analysis
  • China East Education (667 HK): Getting More Interesting
  • [Counting Beans #2] Soybean Prices Maintain Support at USc 1,300
  • Ricegrowers Limited (SunRice) – Earnings Visibility Improves into FY26
  • Games Workshop Group – Licensed content agreement with Amazon
  • Tsuruha: What Next: Go Private or Aeon?


Oriental Land: Approaching the Tipping Point

By Oshadhi Kumarasiri

  • Google Search trends for Tokyo Disneyland and DisneySea in recent months point to potential vulnerabilities in Oriental Land’s FQ3 performance.
  • Tokyo Disneyland’s rising ticket prices have narrowed the cost gap with Shanghai and Hong Kong Disneyland, potentially leading to a loss of customers to its counterparts.
  • Should Oriental Land (4661 JP) shares fail to surpass its recent peak in January next year, we think shares could undergo a rather substantial correction.

Kurabo (3106) – Bigly Buyback And Share Cancellation for A Valueful Value Trap With Hidden Value

By Travis Lundy

  • Kurabo announced a bigly buyback on Tuesday. At last price it is equivalent to 8+% of shares out. Most likely to target buybacks from cross-holders. 
  • The company is not cash-rich, but it is financial asset and real estate-rich. And it trades at cheap multiples without even thinking about those assets (themselves worth the market cap).
  • The TSE’s “PBR1 OR BUST” movement combined with starting low valuation, high payout, excess assets, mean this value trap has room to move. 

StubWorld: Hankook’s Bothersome Brothers

By David Blennerhassett

  • The Cho brothers are currently sparring over control of Hankook & Company (000240 KS), and in turn, its 30.7% stake in Hankook Tire (161390 KS).
  • After the honorary chairman of Hankook backed the younger son (& chairman of Hankook), PE-outfit MBK, aligned with the elder son, bumped its public tender Offer by 20% to ₩24,000/share.
  • Hankook is currently trading 27.3% adrift of the revised terms. That pretty much sums up the situation. The public tender closes on December 25. However, December 23-25 are holidays.

Credo Brands Marketing IPO- Forensic Analysis

By Nitin Mangal

  • Credo Brands (Mufti) (CREDO IN) IPO opens as a full OFS worth INR 5.5 bn. 
  • The company operates ‘Mufti’ which is one of the renowned brands in Indian Men Casual Fashion category. 
  • CMBL faces several questions including employee pay vs KMP, accounting for unsold inventory, delay in important payments, conflict of interest with BoD/SMPs etc.

China East Education (667 HK): Getting More Interesting

By Osbert Tang, CFA

  • China East Education (667 HK) is interesting as it is probably the only education company with no debt. Net cash amounted to Rmb2.1bn, or 42% of its market capitalisation. 
  • Earnings have bottomed out and the marginal YoY decline in 1H23 is due to upfront costs for staff recruitment. Its vocational education focus also faces fewer regulatory risks.
  • We consider it a potential privatisation candidate at 0.8x P/B. Its major shareholders owned 75% of the company, leaving a free float of less than HK$1.4bn.

[Counting Beans #2] Soybean Prices Maintain Support at USc 1,300

By Pranay Yadav

  • Soybean futures maintained above USc 1,300/bushel indicating continued strong support at the level.
  • Large export sales announcements continued over the last week, through November, net Soybean sales from the US were higher than their 5Y average. December pace remains strong too.
  • CONAB cut production forecast for Soybean in Brazil due to unfavorable weather over November. Weather has improved recently with rains expected in key agricultural region.

Ricegrowers Limited (SunRice) – Earnings Visibility Improves into FY26

By Research as a Service (RaaS)

  • Ricegrowers Limited, trading as SunRice (ASX:SGLLV), has released its H1 FY24 results, delivering RaaS adjusted EBITDA of $69m (+68%) and adjusted NPAT of $33.3m (+107%), both well above RaaS estimates of $57.6m and $25m respectively.
  • Divisionally the key surprise was International, delivering adjusted EBITDA of $33m, 125% above the PCP and 57% above RaaS estimates on the back of increases scale and reach, price increases and lower freight costs.
  • Operating cash flow was the strongest since H2 FY18 despite a high tax payment as working capital improved from lower receivables and inventory reductions. 

Games Workshop Group – Licensed content agreement with Amazon

By Edison Investment Research

Games Workshop Group (GAW) has signed an agreement with Amazon Content Services, a subsidiary of Amazon.com, to prospectively develop GAW’s intellectual property (IP) into film and television content and to grant associated merchandising rights, initially focused on the Warhammer 40k universe. The partnership follows the announcement in December 2022 when management said an agreement had been reached in principle. Although the content will mainly be focused on GAW’s Warhammer 40k, Amazon has the option to develop other IP within GAW’s fantasy universe following the initial release. The first year has been set out as a period for creative discussions, after which the agreement will go ahead if both GAW and Amazon sign off on the creative guidelines.


Tsuruha: What Next: Go Private or Aeon?

By Michael Causton

  • Tsuruha sees itself as another recent victim of activist fund pressure. 
  • The No. 2 drugstore chain has grown successfully over the past decade and today has the widest store coverage of any chain in its sector.
  • This summer Aeon supported activists’ demand for strategic change. Tsuruha thinks the only way it can keep its independence may be to take the company private – Aeon probably agrees.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Australia: Azure Minerals, Lithium Power International, Ricegrowers Ltd, Neuren Pharmaceuticals and more

By | Australia, Daily Briefs

In today’s briefing:

  • Gina Joins SQM In Bid For Azure (AZS AU)
  • Azure Minerals (AZS AU): SQM/Hancock Team up for a New Offer
  • Lithium Power (LPI AU): Scheme Vote on 23 January
  • Codelco’s Offer For Lithium Power (LPI AU): 23th Jan Shareholder Vote
  • Ricegrowers Limited (SunRice) – Earnings Visibility Improves into FY26
  • Neuren Pharmaceuticals (NEU AU): Positive Trial Result- A Step Ahead for Potential Second Drug


Gina Joins SQM In Bid For Azure (AZS AU)

By David Blennerhassett

  • This makes life a lot simpler. Gina Rinehart’s Hancock Prospecting will now team up with Chile’s SQM to take control of lithium play Azure Minerals (AZS AU).
  • In a binding Offer, by way of a Scheme, the joint bidders (collectively holding ~37.79%) are offering A$3.70/share, a 5.1% bump in terms to SQM’s prior Scheme Offer. 
  • An off-market takeover at A$3.65/share unfolds IF this Scheme were to fail. If both fail/lapse,  SQM will, “in certain circumstances”, be required to proceed with its off-market transaction of A$3.50/share.

Azure Minerals (AZS AU): SQM/Hancock Team up for a New Offer

By Arun George

  • Azure Minerals (AZS AU) has entered a new transaction implementation deed with Sociedad Quimica y Minera de Chile (SQM US) and Hancock at A$3.70, a 51.6% premium to the undisturbed price.
  • The emergence of Hancock and Mineral Resources (MIN AU) as substantial shareholders necessitated the new offer. The off-market takeover offer is A$3.65 per share if the scheme fails. 
  • The scheme’s completion hinges on MinRes’ acceptance. MinRes could potentially block the scheme but has a history of selling into Hancock offers.

Lithium Power (LPI AU): Scheme Vote on 23 January

By Arun George

  • The Lithium Power International (LPI AU) IE considers Codelco’s A$0.57 offer fair and reasonable as it is above the midpoint of its A$0.30-0.68 per share valuation range. 
  • The scheme is conditional on FIRB approval, which should be forthcoming as LPI’s assets are outside Australia in Chile.
  • Irrevocables represent 32.05% of outstanding shares. At the last close and for the 16 February payment, the gross/annualised spread was 3.6%/26.3%.

Codelco’s Offer For Lithium Power (LPI AU): 23th Jan Shareholder Vote

By David Blennerhassett

  • Back on the 18th October, Lithium Power International (LPI AU) announced it had entered into a Scheme Implementation Deed with Chilean state miner Codelco, the world’s largest copper producer.
  • Codelco offered LPI shareholders A$0.57/share, a heft 119% premium to last close. LPI’s major shareholder, Minera Salar Blanco SpA with 27.88%, is supportive of the Scheme.. 
  • LPI’s Scheme Meeting has now been tabled for the 23 Jan, with implementation expected on the 16 February. The IE is supportive and LPIs board unanimously recommends the transaction.

Ricegrowers Limited (SunRice) – Earnings Visibility Improves into FY26

By Research as a Service (RaaS)

  • Ricegrowers Limited, trading as SunRice (ASX:SGLLV), has released its H1 FY24 results, delivering RaaS adjusted EBITDA of $69m (+68%) and adjusted NPAT of $33.3m (+107%), both well above RaaS estimates of $57.6m and $25m respectively.
  • Divisionally the key surprise was International, delivering adjusted EBITDA of $33m, 125% above the PCP and 57% above RaaS estimates on the back of increases scale and reach, price increases and lower freight costs.
  • Operating cash flow was the strongest since H2 FY18 despite a high tax payment as working capital improved from lower receivables and inventory reductions. 

Neuren Pharmaceuticals (NEU AU): Positive Trial Result- A Step Ahead for Potential Second Drug

By Tina Banerjee

  • Neuren Pharmaceuticals (NEU AU) has announced positive top-line result from its phase 2 clinical trial of its second drug candidate NNZ-2591 in children with Phelan-McDermid syndrome (PMS), a genetic disorder.
  • PMS has an overwhelming unmet medical need. This is an attractive commercial opportunity with an estimated addressable patient population of 24,000 in the U.S. alone.
  • NNZ-2591 has the potential to become the first FDA-approved drug for PMS. Neuren is also conducting phase 2 clinical trials of NNZ-2591 in children with three other neurodevelopmental disorders.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief South Korea: Pan Ocean, Hankook & Company and more

By | Daily Briefs, South Korea

In today’s briefing:

  • Pan Ocean Considering on a Rights Offering Capital Raise of Nearly 3 Trillion Won for the HMM Deal
  • StubWorld: Hankook’s Bothersome Brothers


Pan Ocean Considering on a Rights Offering Capital Raise of Nearly 3 Trillion Won for the HMM Deal

By Douglas Kim

  • A consortium led by the Harim Group and JKL Partners has been chosen as the preferred bidder to acquire a 57.9% stake in HMM.
  • Korea Development Bank (KDB) and the Korea Ocean Business Corporation (KOBC) are the main creditors of HMM, which is the largest shipping company in Korea.
  • Pan Ocean is expected to complete a rights offering of nearly 3 trillion won which is 136% of its current market cap. This is excessive and negative for Pan Ocean.

StubWorld: Hankook’s Bothersome Brothers

By David Blennerhassett

  • The Cho brothers are currently sparring over control of Hankook & Company (000240 KS), and in turn, its 30.7% stake in Hankook Tire (161390 KS).
  • After the honorary chairman of Hankook backed the younger son (& chairman of Hankook), PE-outfit MBK, aligned with the elder son, bumped its public tender Offer by 20% to ₩24,000/share.
  • Hankook is currently trading 27.3% adrift of the revised terms. That pretty much sums up the situation. The public tender closes on December 25. However, December 23-25 are holidays.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Thailand: Ngern Tid Lor and more

By | Daily Briefs, Thailand

In today’s briefing:

  • SET50 Index Rebalance: KCE Replaces TIDLOR


SET50 Index Rebalance: KCE Replaces TIDLOR

By Brian Freitas


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: Taiwan Semiconductor (TSMC), Soybean Active Contract, iShares Russell 2000 ETF, Gaia, Steelcase Inc Cl A and more

By | Daily Briefs, United States

In today’s briefing:

  • TSMC Chairman to Retire, + or — Impacts to Shareholders
  • [Counting Beans #2] Soybean Prices Maintain Support at USc 1,300
  • Russell 2000 Testing 1.5+ Year Resistance; Downgrading Communications; Steel Buys $NUE $STLD $ZEUS
  • Gaia, Inc. – Good Momentum Going into 2024
  • Steelcase, Inc. – Earnings After Close Today; Watching Margins, Order Trends


TSMC Chairman to Retire, + or — Impacts to Shareholders

By Andrew Lu

  • Chairman 69 years old Dr. Liu will retire and 70 years old CEO Dr. Wei will step up. What story do we believe? Will TSMC to regain its strong outperperformance?
  • Positive impacts: we expect Arizona fab equipment move-in and ramp up might be further delayed if no subsidies are granted; two teams competing to one voice/team/direction.
  • Three risks: 1. Dr. Wei at his age of 70 without a strong management backup; 2. Dr. Wei might make a wrong decision deeply; 3. absolute power corrupts.

[Counting Beans #2] Soybean Prices Maintain Support at USc 1,300

By Pranay Yadav

  • Soybean futures maintained above USc 1,300/bushel indicating continued strong support at the level.
  • Large export sales announcements continued over the last week, through November, net Soybean sales from the US were higher than their 5Y average. December pace remains strong too.
  • CONAB cut production forecast for Soybean in Brazil due to unfavorable weather over November. Weather has improved recently with rains expected in key agricultural region.

Russell 2000 Testing 1.5+ Year Resistance; Downgrading Communications; Steel Buys $NUE $STLD $ZEUS

By Joe Jasper

  • The market remains in “lockout rally” mode, where prices continue to move higher with little-to-no pullbacks, while ignoring overbought readings.
  • We have discussed this on a weekly basis since 11/21/23. Still no reason to fight this bullish trend, and we continue to expect more upside into year-end and early 2024.
  • We highlight buys in Steel: NUE, STLD, RS, WOR, TMST, ZEUS, LatAm Banks: ITUB, BSBR, BBD, BAP, BCH, Industrials: ITT, FSS, SPXC, ATS, KAI, CR, BRC, SXI, and HSC

Gaia, Inc. – Good Momentum Going into 2024

By Water Tower Research

  • We recently caught up with management to congratulate James Colquhoun on his promotion to CEO.
  • We also got a good update on the business as well as some early indications of trends and management focus for 2024.
  • As indicated on the 3Q23 earnings call, new member growth is continuing at a healthy clip and management expects to close 2023 at around 800k members.

Steelcase, Inc. – Earnings After Close Today; Watching Margins, Order Trends

By Water Tower Research

  • Steelcase reports 3QFY24 results after market close today. We are expecting adjusted EPS of $0.25 on revenue of $804 million.
  • Consensus is EPS of $0.23 on revenue of $796 million.
  • Our estimate is at the high end of the revenue guidance and the midpoint of adjusted EPS guidance. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Bharat Electronics, India Shelter Finance, Union Bank Of India, Credo Brands Marketing, Stylam Industries and more

By | Daily Briefs, India

In today’s briefing:

  • Quiddity Leaderboard NIFTY Mar 24: Bharat Electronics Trade Successful; Change Hedge and Let It Run
  • India Shelter Finance IPO Trading – Subscription Pulled by Strong Insti Demand
  • AMFI Stock Reclassification Preview (Dec 2023): MidCap to LargeCap Migrations Outperforming
  • Credo Brands Marketing IPO- Forensic Analysis
  • Stylam Industries (SYIL IN): Sluggish Exports, FY25 To See Improvements With Expansion


Quiddity Leaderboard NIFTY Mar 24: Bharat Electronics Trade Successful; Change Hedge and Let It Run

By Janaghan Jeyakumar, CFA

  • NIFTY 50 represents the 50 largest stocks listed in the National Stock Exchange (NSE) of India and the NIFTY Next 50 index tracks the next 50 largest names.
  • In this insight, we take a look at the names leading the race to become ADDs/DELs for the NIFTY 50 and NIFTY Next 50 indices in the March 2024 rebalance.
  • There could be multiple changes for NIFTY 50 and separately, there could be five changes for NIFTY Next 50. The NIFTY 50 changes could have high impact.

India Shelter Finance IPO Trading – Subscription Pulled by Strong Insti Demand

By Clarence Chu

  • India Shelter Finance (0570670D IN) raised around US$144m from its India IPO.
  • India Shelter Finance (ISF) is a retail-focused HFC targeting the self-employed customer with a focus on first time home loan takers in the low and middle income group.
  • We have covered various aspects of the deal in our previous note. In this note, we will talk about the demand and trading dynamics.

AMFI Stock Reclassification Preview (Dec 2023): MidCap to LargeCap Migrations Outperforming

By Brian Freitas

  • We see 8 stocks moving from MidCap to LargeCap, 8 stocks moving from LargeCap to MidCap, 11 stocks from SmallCap to MidCap, and 14 stocks from MidCap to SmallCap.
  • Some stocks were added to global indices last month while some could be added in February. There are potential index implications for the NIFTY Index and Nifty Next 50 Index too.
  • The upward migrations have continued to outperform the downward migrations. The largest recent outperformance has come from stocks expected to move from the Mid Cap to the Large Cap segment.

Credo Brands Marketing IPO- Forensic Analysis

By Nitin Mangal

  • Credo Brands (Mufti) (CREDO IN) IPO opens as a full OFS worth INR 5.5 bn. 
  • The company operates ‘Mufti’ which is one of the renowned brands in Indian Men Casual Fashion category. 
  • CMBL faces several questions including employee pay vs KMP, accounting for unsold inventory, delay in important payments, conflict of interest with BoD/SMPs etc.

Stylam Industries (SYIL IN): Sluggish Exports, FY25 To See Improvements With Expansion

By Sameer Taneja

  • While the profitability of Stylam Industries (SYIL IN) is growing healthily (>30% YoY) in H1 FY24 due to margin expansion, revenues are trending at -4.5% YoY.
  • The company became net cash in H1 FY24 (73 crore INR)  and zero gross debt. A strong balance sheet would aid in the company’s expansion plans. 
  • Trading at 23x/18x FY24e/25e, we see strong growth ahead for the company as it cements its position as one of India’s top laminate export players. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars